Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. UBE235250

R&D Systems™ Human RAP80 UIM Domains Biotin Recombinant Protein

Catalog No. UBE235250
Change view
Click to view available options
250ug; Carrier Free
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
UBE235250 250ug; Carrier Free
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. UBE235250 Supplier R&D Systems™ Supplier No. UBE235250
This item is not returnable. View return policy

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human RAP80 UIM Domains Biotin Protein is derived from E. coli. The Recombinant Human RAP80 UIM Domains Biotin Protein has been validated for the following applications: Enzyme Activity.

Specifications

Formulation Supplied as a solution in HEPES, NaCl, DTT and Glycerol.
Gene ID (Entrez) 51720
Name RAP80 UIM Domains Biotin
Quantity 250μg
Source E. coli-derived
Storage Requirements Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -70° C as supplied. 3 months, -70° C under sterile conditions after opening.
Conjugate Biotin
Recombinant Recombinant
Purity or Quality Grade 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.